Approval of a cheap version of HIV-prevention shot lenacapavir raises hopes in low-income countries
Headline from Washington Times · First reported · Updated · 3 sources, 3 articles
World
Image: Washington Times
What's being reported
The U.S. Food and Drug Administration has approved a generic version of the world's only twice-a-year shot to prevent HIV - a big step toward making the drug available inexpensively and more quickly in 120 low- and middle-income countries.
Summary from Washington Times. Read every outlet's version below.Same story, different headlines
Left2
Promising new HIV-prevention drug is hard to find where it's most needed
Experts say that a promising drug that offers complete protection against HIV and requires only two shots a year isn't getting to enough people
US approves cheap generic version of breakthrough HIV prevention jab – in major step towards ending Aids
The Lenacapavir injection will cost just $40 a year in 120 countries, in what is seen as a major step towards ending Aids
Center0
No center outlets in our sources have covered this yet.
